IMMUCELL CORP /DE/ Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Immucell Corp /De/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Immucell Corp /De/ Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $77.6K, a 19.6% decline year-over-year.
  • Immucell Corp /De/ Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $357K, a 7.12% increase year-over-year.
  • Immucell Corp /De/ annual Share-based Payment Arrangement, Expense for 2023 was $369K, a 38.5% increase from 2022.
  • Immucell Corp /De/ annual Share-based Payment Arrangement, Expense for 2022 was $266K, a 84.5% increase from 2021.
  • Immucell Corp /De/ annual Share-based Payment Arrangement, Expense for 2021 was $144K, a 43% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $369K +$103K +38.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $266K +$122K +84.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $144K -$109K -43% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $253K -$60K -19.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $313K -$30.9K -8.97% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $344K +$144K +72.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $200K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.